PCRX Stock-Based Compensation
Pacira Biosciences Inc · Stock-Based Compensation
PCRX Stock-Based Compensation
Latest reported$14.96Mperiod ending
PCRX Quarterly Stock-Based Comp ($5.00K → $14.96M)
Quarterly stock-based compensation
High-resolution chart · PNG
PCRX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 14,958,000 | |
| 13,539,000 | |
| 13,499,000 | |
| 13,978,000 | |
| 15,472,000 | |
| 14,553,000 | |
| 12,266,000 | |
| 13,230,000 | |
| 12,524,000 | |
| 13,151,000 | |
| 12,420,000 | |
| 12,530,000 | |
| 10,955,000 | |
| 11,990,000 | |
| 12,677,000 | |
| 12,682,000 | |
| 11,544,000 | |
| 11,189,000 | |
| 0 | |
| 10,785,000 | |
| 10,461,000 | |
| 10,110,000 | |
| 10,896,000 | |
| 10,954,000 | |
| 9,223,000 | |
| 0 | |
| 9,189,000 | |
| 9,244,000 | |
| 7,783,000 | |
| 7,434,000 | |
| 8,186,000 | |
| 8,107,000 | |
| 7,047,000 | |
| 8,385,000 | |
| 8,194,000 | |
| 8,663,000 | |
| 7,344,000 | |
| 7,400,000 | |
| 7,732,000 | |
| 7,361,000 | |
| 7,665,000 | |
| 8,490,000 | |
| 9,728,000 | |
| 8,827,000 | |
| 7,296,000 | |
| 7,517,000 | |
| 7,623,000 | |
| 7,687,000 | |
| 5,537,000 | |
| 3,975,000 | |
| 3,286,000 | |
| 3,777,000 | |
| 2,225,000 | |
| 2,225,000 | |
| 1,556,000 | |
| 1,469,000 | |
| 1,039,000 | |
| 712,000 | |
| 528,000 | |
| 442,000 | |
| 551,000 | |
| 972,000 | |
| 6,000 | |
| 6,000 | |
| 6,000 | |
| 5,000 | |
| 6,000 | |
| 5,000 |